A review of the use of psychotropic medications for people with developmental disabilities is presented. Results suggest that prescribing drugs based on topographical features of the problem behavior, without considering the function the behavior serves for the individual, contributes to variability in clinical response. Functional analysis of a behavior disorder is urged prior to pharmacotherapy. (Author/DB)